1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow KB105: new trials by email Literature Review of KB105 trials Research Report on KB105
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) KB105 - TGM-1 Related Autosomal Recessive Congenital Ichthyosis | Phase 1 / Phase 2 | Unknown | Krystal Biotech, Inc. | 6 | 2019-08-27 | 2021-09-13 |
United States (1)